• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETBF2813C145E
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Occlusion (1984); Injury (2348)
Date of Event 07/09/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The main component of the system.Other relevant device(s) are: product id: etlw1616c93e, serial/lot #: (b)(4), ubd: (b)(6) 2020, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant ii stent graft system was implanted in a patient for the endovascular treatment of an abdominal aortic aneurysm of unknown size.It was reported that during patient follow up, a ct scan identified an occlusion.It was reported that the left side of the graft became occluded, with the occlusion beginning at the flow divider and extending through the external iliac artery.Blood flow is then resuming in the femoral artery.The physician attempted to perform a thrombectomy, but was unsuccessful and a fem-fem bypass was performed instead.The issue was resolved.Per the physician, the cause of the event is uncertain but the physician noted that the occlusion may have originated at the narrowing at the proximal left common iliac artery.No additional clinical sequelae were reported and the patient is fine.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key7800490
Report Number2953200-2018-01181
Device Sequence Number1928103
Product Code MIH
UDI-Device Identifier00613994991294
UDI-Public00613994991294
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/27/2020
Device Model NumberETBF2813C145E
Device Catalogue NumberETBF2813C145E
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 07/24/2018
Supplement Date Received by Manufacturer11/15/2018
Initial Report FDA Received Date08/21/2018
Supplement Report FDA Received Date11/21/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age82 YR
-
-